Griseofulvin

Griseofulvin is an antifungal medication that must adhere to strict pharmacopeial standards. Buyers should ensure the product complies with USP (United States Pharmacopeia), BP (British Pharmacopeia), or EP (European Pharmacopeia) standards. Key specifications include purity levels (typically ≥99%), particle size distribution (microsize or ultramicrosize, as this affects bioavailability), and loss on drying (≤0.5%). Always request a Certificate of Analysis (CoA) for every batch to verify these parameters.

As a pharmaceutical active ingredient (API), the supplier must possess a GMP (Good Manufacturing Practice) certificate. For entry into regulated markets, look for suppliers with a CEP (Certificate of Suitability) or a DMF (Drug Master File) number registered with the FDA or EMA. Ensure the manufacturer is registered with the relevant national health authority and can provide a Written Confirmation (WC) for active substances exported to the EU.

Griseofulvin is available in microsize and ultramicrosize forms. Ultramicrosize Griseofulvin has significantly higher absorption rates in the gastrointestinal tract, allowing for lower dosages compared to the microsize version. Buyers must clarify the intended final dosage form (tablets, capsules, or oral suspensions) to select the correct micronization level and ensure therapeutic equivalence.

Griseofulvin is relatively stable but is light-sensitive. It should be stored in tight, light-resistant containers at controlled room temperatures (15°C to 30°C). During cross-border shipping, ensure the packaging includes UV-protective liners and that the cargo is kept away from high humidity to prevent degradation of the active ingredient.

The biggest risks include substandard purity, counterfeit documentation, and regulatory rejection at customs. To mitigate this, use Made-in-China.com’s audited supplier reports to verify the factory's existence and production capacity. Conduct third-party pre-shipment inspections (e.g., SGS or Intertek) to test samples directly from the production line before final payment.

Pharmaceutical production often runs in batches. Negotiate for 'Campaign-based' production if your volume is high to ensure batch consistency. For smaller buyers, look for suppliers who maintain safety stock of GMP-grade material. Typical MOQs for APIs range from 10kg to 25kg (standard drum size). Request a tiered pricing structure where costs decrease by 10-15% as volume crosses the 100kg threshold.

Always use Secured Payment terms or Letters of Credit (L/C) for large volumes to ensure funds are only released upon presentation of valid shipping and quality documents. Avoid using anonymous wire transfers. Ensure the Proforma Invoice (PI) clearly states the HS Code (typically 2932.20), purity, and the specific pharmacopeia standard to be met.

Ensure the supplier provides a Material Safety Data Sheet (MSDS) and a Non-Dangerous Goods Certificate (if applicable) to prevent delays during air or sea freight. For customs clearance, the importer must have a valid pharmaceutical import license in their destination country. Failure to provide the Import Declaration for Drugs can lead to immediate seizure of the goods by customs authorities.